Volume 7, Number 7—June 2001
International Conference on Emerging Infectious Diseases 2000
Conference Panel Summary
GIDEON: A Computer Program for Diagnosis, Simulation, and Informatics in the Fields of Geographic Medicine and Emerging Diseases
Highlight and copy the desired format.
|EID||Berger SA. GIDEON: A Computer Program for Diagnosis, Simulation, and Informatics in the Fields of Geographic Medicine and Emerging Diseases. Emerg Infect Dis. 2001;7(7):550. https://dx.doi.org/10.3201/eid0707.017729|
|AMA||Berger SA. GIDEON: A Computer Program for Diagnosis, Simulation, and Informatics in the Fields of Geographic Medicine and Emerging Diseases. Emerging Infectious Diseases. 2001;7(7):550. doi:10.3201/eid0707.017729.|
|APA||Berger, S. A. (2001). GIDEON: A Computer Program for Diagnosis, Simulation, and Informatics in the Fields of Geographic Medicine and Emerging Diseases. Emerging Infectious Diseases, 7(7), 550. https://dx.doi.org/10.3201/eid0707.017729.|
Over 300 infectious diseases occur and are challenged by over 250 drugs and vaccines. Fifteen hundred species of pathogenic bacteria, viruses, parasites and fungi have been described. Printed media can no longer keep up with the dynamics of diseases, outbreaks, and epidemics in "real time." Although electronic media has given us unlimited information access, the search for meaningful data is confusing and time-consuming. Global Infectious Diseases and Epidemiology Network (GIDEON) is a computer software program that was developed for disease simulation and informatics in the fields of geographic and travel medicine. GIDEON is currently used in 1,500 sites in 45 countries: health ministries, military installations, travel clinics, libraries and student teaching modules, clinical departments, laboratories, and missionary agencies. The program consists of four components. The first generates a Bayesian ranked differential diagnosis based on signs, symptoms, laboratory tests, country of origin, and incubation period and can be used for diagnostic support and simulation of all infectious diseases in all countries. In a blind trial done on 495 patients, the correct diagnosis was included in the differential diagnosis list in 94.7% of cases (sensitivity) and displayed as the first disease in the list in 75% (specificity).
The second component presents the epidemiology of individual diseases, including their global effects and status in each of 205 countries and regions. All past and current outbreaks are described in detail, and a web-based version under development will allow for daily updating online. The user may also access a list of diseases related to any agent, vector, vehicle, reservoir or country or any combination of all five (i.e., a list all of mosquitoborne viruses of Brazil which have an avian reservoir).
The third module is an interactive encyclopedia which includes information on the pharmacology, use, testing standards, and global trade names of all antiinfective drugs and vaccines.
The fourth module is designed to identify all species of bacteria, mycobacteria, and yeasts. The database includes 50 to 100 additional taxa that may not appear in standard texts and laboratory databases for several months. Other options allow the user to add data relevant to his own institution, electronic patient charts, material from the Internet, important telephone numbers, drug prices, antimicrobial resistance patterns, and other information. This form of custom data input is particularly useful when running GIDEON on institutional networks because software administrators can use it to disseminate and file information relevant to their own institution for use by all computers on their network.
The data in GIDEON are derived from all peer-reviewed journals in the fields of infectious diseases, pediatrics, internal medicine, tropical medicine, travel medicine, antimicrobial pharmacology, and clinical microbiology; a monthly electronic literature search based on all relevant terms in GIDEON (e.g., diseases, drugs, etc.) all available health ministry reports (both printed and electronic); standard texts; and abstracts of major meetings. Further details regarding the program are available at http://www.cyinfo.comCite This Article
Please use the form below to submit correspondence to the authors or contact them at the following address:
Stephen A. Berger, 6 Weitzman Street, Tel Aviv 64239, Israel, Tel: +972 3 6973263, Fax: +972 3 6132892,
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: April 27, 2012
- Page last updated: April 27, 2012
- Page last reviewed: April 27, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)